US Patent Issued to BEIJING HANMI PHARMACEUTICAL on June 10 for "Anti-TNFAlpha/anti IL-17A natural antibody structure-like heterodimer form of bispecific antibody and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,743, issued on June 10, was assigned to BEIJING HANMI PHARMACEUTICAL Co. LTD. (Beijing).

"Anti-TNFAlpha/anti IL-17A natural antibody structure-like heterodimer form of bispecific antibody and preparation method therefor" was invented by Jiawang Liu (Beijing), Yaping Yang (Beijing), Nanmeng Song (Beijing), Wenchu Xiao (Beijing), Chulwoong Chung (Beijing) and Maengsup Kim (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-TNFAlpha/anti IL-17A natural antibody structure-like heterodimer form of a bispecific antibody and a preparation method therefor, wherein the antibody can bind two target molecules simultaneously, and can be...